1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC et al : Clinical Characteristics of Coronavirus Disease 2019 in China . N Engl J Med 2020,382 (18):1708-1720.

2. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang Met al : Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study . Lancet Respir Med 2020,8 (5):475-481.

3. Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL:Impact of sex and gender on COVID-19 outcomes in Europe .Biol Sex Differ 2020, 11 (1):29.

4. Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P et al : Factors associated with COVID-19-related death using OpenSAFELY . Nature2020, 584 (7821):430-436.

5. Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, Silva J, Mao T, Oh JE, Tokuyama M et al : Sex differences in immune responses that underlie COVID-19 disease outcomes .Nature 2020, 588 (7837):315-320.

6. Paleiron N, Mayet A, Marbac V, Perisse A, Barazzutti H, Brocq FX, Janvier F, Bertrand D, Bylicki O: Impact of Tobacco Smoking on the risk of COVID-19.A large scale retrospective cohort study .Nicotine Tob Res 2021.

7. Asselta R, Paraboschi EM, Mantovani A, Duga S: ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy . Aging (Albany NY)2020, 12 (11):10087-10098.

8. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X et al : Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China . Lancet 2020,395 (10223):497-506.

9. Qian GQ, Yang NB, Ding F, Ma AHY, Wang ZY, Shen YF, Shi CW, Lian X, Chu JG, Chen L et al : Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series . QJM 2020,113 (7):474-481.

10. Chen D, Li X, Song Q, Hu C, Su F, Dai J, Ye Y, Huang J, Zhang X:Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China . JAMA Netw Open 2020, 3 (6):e2011122.

11. Allardet-Servent J, Lebsir M, Dubroca C, Fabrigoule M, Jordana S, Signouret T, Castanier M, Thomas G, Soundaravelou R, Lepidi A, Delapierre L, Penaranda G, Halfon P, Seghboyan JM. Point-of-Care Versus Central Laboratory Measurements of Hemoglobin, Hematocrit, Glucose, Bicarbonate and Electrolytes: A Prospective Observational Study in Critically Ill Patients . PLoS One . 2017 Jan 10;12 (1):e0169593.

12. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group . Ann Intern Med 1999,130 (6):461-470.

13. Kafkas, Ş., Abdelhakim, M., Hashish, Y. et al. PathoPhenoDB, linking human pathogens to their phenotypes in support of infectious disease research. Sci Data 6, 79 (2019)

14. Brosnihan KB, Neves LA, Joyner J, Averill DB, Chappell MC, Sarao R, Penninger J, Ferrario CM: Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy . Hypertension2003, 42 (4):749-753.

15. Brosnihan KB, Hodgin JB, Smithies O, Maeda N, Gallagher P:Tissue-specific regulation of ACE/ACE2 and AT1/AT2 receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor-alpha knock-out mice . Exp Physiol 2008, 93 (5):658-664.

16. Fernandez-Atucha A, Izagirre A, Fraile-Bermudez AB, Kortajarena M, Larrinaga G, Martinez-Lage P, Echevarria E, Gil J: Sex differences in the aging pattern of renin-angiotensin system serum peptidases . Biol Sex Differ 2017, 8 :5.

17. Catalano A, Chila D, Bellone F, Nicocia G, Martino G, Loddo I, Morabito N, Benvenga S, Loddo S: Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? J Clin Transl Endocrinol 2018, 13 :9-13.

18. Catalano A, Morabito N, Basile G, Fusco S, Castagna G, Reitano F, Albanese RC, Lasco A: Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina . Clin Cases Miner Bone Metab 2013,10 (3):191-194.

19. Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, Geng Q, Auerbach A, Li F: Structural basis of receptor recognition by SARS-CoV-2 .Nature 2020, 581 (7807):221-224.

20. Santos RA, Campagnole-Santos MJ, Andrade SP:Angiotensin-(1-7): an update . Regul Pept 2000,91 (1-3):45-62.

21. Simoes-e-Silva AC, Baracho NC, Passaglio KT, Santos RA:Renal actions of angiotensin-(1-7) . Braz J Med Biol Res1997, 30 (4):503-513.

22. Caruso-Neves C, Lara LS, Rangel LB, Grossi AL, Lopes AG:Angiotensin-(1-7) modulates the ouabain-insensitive Na+-ATPase activity from basolateral membrane of the proximal tubule .Biochim Biophys Acta 2000, 1467 (1):189-197.

23. Lara LS, Bica RB, Sena SL, Correa JS, Marques-Fernandes MF, Lopes AG, Caruso-Neves C: Angiotensin-(1-7) reverts the stimulatory effect of angiotensin II on the proximal tubule Na(+)-ATPase activity via a A779-sensitive receptor . Regul Pept 2002,103 (1):17-22.

24. Maiese A, Manetti AC, La Russa R, Di Paolo M, Turillazzi E, Frati P, Fineschi V: Autopsy findings in COVID-19-related deaths: a literature review . Forensic Sci Med Pathol 2020.

25. Werion A, Belkhir L, Perrot M, Schmit G, Aydin S, Chen Z, Penaloza A, De Greef J, Yildiz H, Pothen L et al : SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule .Kidney Int 2020, 98 (5):1296-1307.

26. Chorin E, Wadhwani L, Magnani S, Dai M, Shulman E, Nadeau-Routhier C, Knotts R, Bar-Cohen R, Kogan E, Barbhaiya C et al : QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin . Heart Rhythm 2020,17 (9):1425-1433.

27. Jankelson L, Karam G, Becker ML, Chinitz LA, Tsai MC: QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review . Heart Rhythm 2020, 17 (9):1472-1479.

28. Rosenberg ES, Dufort EM, Udo T, Wilberschied LA, Kumar J, Tesoriero J, Weinberg P, Kirkwood J, Muse A, DeHovitz J et al :Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State .JAMA 2020, 323 (24):2493-2502.

29. Merino JL, Martinez-Cossiani M, Iniesta A, Escobar C, Rey JR, Castrejon-Castrejon S: COVID-19 and QT interval prolongation: more than just drug toxicity? Europace 2020,22 (10):1479.

30. Pani A, Lauriola M, Romandini A, Scaglione F: Macrolides and viral infections: focus on azithromycin in COVID-19 pathology .Int J Antimicrob Agents 2020, 56 (2):106053.

31. ESC guidance for diagnosis and manage- ment of cv disease during the covid-19 pandemic . 2020.

32. Lauriola M, Pani A, Ippoliti G, Mortara A, Milighetti S, Mazen M, Perseghin G, Pastori D, Grosso P, Scaglione F: Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID-19 . Clin Transl Sci 2020,13 (6):1071-1076.